Paediatric computed tomography and subsequent risk of leukaemia, intracranial malignancy and lymphoma: a nationwide population-based cohort study.
I-Gung LiYao-Hsu YangYiu-Tai LiYuan-Hsiung TsaiPublished in: Scientific reports (2020)
Red bone marrow and brain tissue are highly radiosensitive in children. We investigate the relationship between childhood computed tomography (CT) exposure and leukaemia, intracranial malignancy and lymphoma. All participants in the study were aged less than 16 years. A total of 1,479 patients in the leukaemia group, 976 patients in the intracranial malignancy group and 301 patients in the lymphoma group were extracted from the Catastrophic Illness Certificate Database in Taiwan as the disease group. In total, 126,677 subjects were extracted from the Longitudinal Health Insurance Database 2010 of the Taiwan National Health Insurance Research Database as the non-disease group. The odds ratios (ORs) and 95% confidence intervals (CIs) for childhood CT exposure and times of childhood CT were estimated. Childhood CT exposure was correlated to the intracranial malignancy group in both one-year (OR = 1.95, 95% CI 1.40-2.71, p < 0.001) and two-year (OR = 1.56, 95% CI 1.04-2.33, p = 0.031) exclusion periods. The time of childhood CT was also correlated to intracranial malignancy in both one-year (OR = 1.69, 95% CI 1.34-2.13, p < 0.001) and two-year (OR = 1.55, 95% CI 1.17-2.04, p = 0.002) exclusion periods. The results indicated that childhood CT exposure was correlated with an increased risk of future intracranial malignancy.
Keyphrases
- computed tomography
- health insurance
- dual energy
- image quality
- contrast enhanced
- end stage renal disease
- positron emission tomography
- ejection fraction
- newly diagnosed
- magnetic resonance imaging
- bone marrow
- chronic kidney disease
- emergency department
- prognostic factors
- early life
- diffuse large b cell lymphoma
- intensive care unit
- healthcare
- optic nerve
- mesenchymal stem cells
- childhood cancer
- resting state
- brain injury
- functional connectivity
- magnetic resonance
- adverse drug
- optical coherence tomography